PT93985A - Processo e produtos intermedios para a preparacao de acidos aceticos oxoftalazinilicos e seus analogos - Google Patents

Processo e produtos intermedios para a preparacao de acidos aceticos oxoftalazinilicos e seus analogos

Info

Publication number
PT93985A
PT93985A PT93985A PT9398590A PT93985A PT 93985 A PT93985 A PT 93985A PT 93985 A PT93985 A PT 93985A PT 9398590 A PT9398590 A PT 9398590A PT 93985 A PT93985 A PT 93985A
Authority
PT
Portugal
Prior art keywords
oxoftalazinyl
analogs
preparation
intermediate products
acetic acids
Prior art date
Application number
PT93985A
Other languages
English (en)
Other versions
PT93985B (pt
Inventor
Banavara Lakshmana Mylari
William James Zembrowski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT93985A publication Critical patent/PT93985A/pt
Publication of PT93985B publication Critical patent/PT93985B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
PT93985A 1989-05-11 1990-05-09 Processo e produtos intermedios para a preparacao de acidos aceticos oxoftalazinilicos e seus analogos PT93985B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/350,997 US4954629A (en) 1989-05-11 1989-05-11 Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof

Publications (2)

Publication Number Publication Date
PT93985A true PT93985A (pt) 1991-01-08
PT93985B PT93985B (pt) 1996-11-29

Family

ID=23379152

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93985A PT93985B (pt) 1989-05-11 1990-05-09 Processo e produtos intermedios para a preparacao de acidos aceticos oxoftalazinilicos e seus analogos

Country Status (30)

Country Link
US (1) US4954629A (pt)
EP (1) EP0397350B1 (pt)
JP (1) JPH035479A (pt)
KR (1) KR920006419B1 (pt)
CN (1) CN1025855C (pt)
AR (1) AR246968A1 (pt)
AT (1) ATE103913T1 (pt)
AU (2) AU618898B2 (pt)
BG (1) BG50609A3 (pt)
CA (1) CA2016504C (pt)
CZ (1) CZ281213B6 (pt)
DD (1) DD294257A5 (pt)
DE (1) DE69007846T2 (pt)
DK (1) DK0397350T3 (pt)
EG (1) EG19082A (pt)
ES (1) ES2063265T3 (pt)
FI (1) FI93959C (pt)
HU (1) HU212304B (pt)
IE (1) IE62591B1 (pt)
IL (3) IL94301A (pt)
MX (2) MX167455B (pt)
NO (1) NO177708C (pt)
NZ (1) NZ233597A (pt)
PH (1) PH26567A (pt)
PL (1) PL164427B1 (pt)
PT (1) PT93985B (pt)
RO (1) RO107256B1 (pt)
RU (1) RU2014333C1 (pt)
YU (1) YU91290A (pt)
ZA (1) ZA903565B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996204A (en) * 1989-05-11 1991-02-26 Pfizer Inc. Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors
IL124236A (en) * 1997-05-05 2003-01-12 Pfizer Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
EP0982306A3 (en) * 1998-08-21 2000-07-05 Pfizer Products Inc. Polymorph of zopolrestat monohydrate
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
EP3192796B1 (en) 2010-07-16 2019-09-04 The Trustees of Columbia University in the City of New York Aldose reductase inhibitors and uses thereof
CN102558184B (zh) * 2011-12-30 2014-07-16 西南大学 酞嗪类衍生物的合成方法
CN102702108A (zh) * 2012-06-27 2012-10-03 上海大学 1,2-二氢酞嗪类化合物及其合成方法
CN102863393A (zh) * 2012-09-26 2013-01-09 上海大学 1,2-二氢酞嗪类化合物及其合成方法
SI3352754T1 (sl) * 2016-06-21 2021-03-31 The Trustees Of Columbia University In The City Of New York Zaviralci aldozne reduktaze in postopki njihove uporabe
CA3071114A1 (en) 2017-07-28 2019-01-31 Applied Therapeutics Inc. Compositions and methods for treating galactosemia
JP2022519944A (ja) 2019-04-01 2022-03-25 アプライド セラピューティクス インコーポレイテッド アルドースレダクターゼの阻害剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
DE3337859A1 (de) * 1983-01-21 1984-07-26 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von benzthiazolen
CA1299178C (en) * 1985-11-07 1992-04-21 Banavara Lakshmana Mylari Heterocyclic oxophtalazinyl acetic acids
ES2032749T3 (es) * 1985-11-07 1993-03-01 Pfizer Inc. Acidos oxoftalazinil-aceticos heterociclicos.
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
EP0322153A3 (en) * 1987-12-21 1990-08-16 Pfizer Inc. Heterocyclic oxophtalazinyl acetic acids
WO1989006651A1 (en) * 1988-01-19 1989-07-27 Pfizer Inc. 1h-indazole-3-acetic acids as aldose reductase inhibitors
US4996204A (en) * 1989-05-11 1991-02-26 Pfizer Inc. Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors

Also Published As

Publication number Publication date
DK0397350T3 (da) 1994-05-09
AU5490690A (en) 1990-11-15
ZA903565B (en) 1991-12-24
AU8680691A (en) 1992-01-02
KR900018114A (ko) 1990-12-20
PL164427B1 (pl) 1994-07-29
EP0397350B1 (en) 1994-04-06
CA2016504A1 (en) 1990-11-11
AR246968A1 (es) 1994-10-31
ATE103913T1 (de) 1994-04-15
PL285113A1 (en) 1991-07-15
IL114271A (en) 1998-04-05
FI93959C (fi) 1995-06-26
AU626225B2 (en) 1992-07-23
MX9207687A (es) 1994-06-30
IE901626L (en) 1990-11-11
IL94301A0 (en) 1991-03-10
CN1025855C (zh) 1994-09-07
EP0397350A1 (en) 1990-11-14
JPH035479A (ja) 1991-01-11
DD294257A5 (de) 1991-09-26
HUT54690A (en) 1991-03-28
JPH0573753B2 (pt) 1993-10-15
RU2014333C1 (ru) 1994-06-15
FI93959B (fi) 1995-03-15
IE62591B1 (en) 1995-02-08
US4954629A (en) 1990-09-04
AU618898B2 (en) 1992-01-09
NO177708C (no) 1995-11-08
IL114271A0 (en) 1995-10-31
CA2016504C (en) 1999-07-27
FI902333A0 (fi) 1990-05-10
DE69007846T2 (de) 1994-07-28
MX167455B (es) 1993-03-23
RO107256B1 (ro) 1993-10-30
KR920006419B1 (ko) 1992-08-06
BG50609A3 (en) 1992-09-15
CZ281213B6 (cs) 1996-07-17
ES2063265T3 (es) 1995-01-01
NZ233597A (en) 1992-02-25
CZ227890A3 (en) 1996-04-17
NO902071D0 (no) 1990-05-10
HU902995D0 (en) 1990-09-28
CN1047499A (zh) 1990-12-05
NO177708B (no) 1995-07-31
PT93985B (pt) 1996-11-29
NO902071L (no) 1990-11-12
HU212304B (en) 1996-05-28
DE69007846D1 (de) 1994-05-11
PH26567A (en) 1992-08-19
EG19082A (en) 1994-07-30
IL94301A (en) 1996-01-19
YU91290A (sh) 1992-09-07

Similar Documents

Publication Publication Date Title
PT88044A (pt) Processo para a preparacao de acidos tetra-hidrocarbazole-1-alcanoicos
BR8800636A (pt) Processo para a preparacao de acidos benzenocarboxilicos e esteres de acidos benzenodicarboxilicos e dispositivo
PT93785A (pt) Processo para a preparacao de derivados de 3-substituido-2-oxindole
BR8904890A (pt) Processo para a preparacao de um produto
PT93452A (pt) Processo para a preparacao de uma pastilha de colestiramina
PT83684B (pt) Processo para a preparacao de acidos heterociclil-oxoftalazinil-aceticos
BR8802484A (pt) Processo para a preparacao de isocianatos
PT92919A (pt) Processo para a preparacao de agentes ansioliticos bis-azabiciclicos
PT90471A (pt) Processo para a preparacao de derivados de cromano e de produtos intermediarios
PT89205A (pt) Processo para a preparacao de derivados de indano
BR8804284A (pt) Processo para a preparacao de acidos etercarboxilicos
PT89075A (pt) Processo para a preparacao de diacidos diarilestiril-quinolinicos
PT90227A (pt) Processo para a preparacao de esteroides de 9 alfa-hidroxi-17-metileno
PT87884A (pt) Processo para a preparacao de acidos e esteres diazabicicloalquil em ponte-quinolono-carboxilicos
PT90808A (pt) Processo para a preparacao de poliesteres de acidos gordos de sacarose
PT89648A (pt) Processo para a preparacao de produto alimentar proteinado
PT89956A (pt) Processo para a preparacao de acidos 1-ciclopropil-quinolonocarboxilicos e seus derivados
BR8802843A (pt) Processo para a preparacao de alcanotriois e alcanopoliois
PT88181A (pt) Processo para a preparacao de derivados aralquilaminoalcoxifenilo
PT95542A (pt) Processo para a prparacao de derivados de fenetanolamina
PT93985A (pt) Processo e produtos intermedios para a preparacao de acidos aceticos oxoftalazinilicos e seus analogos
PT83074B (pt) Processo para a preparacao de produtos de solvatacao de 3-propenil-cefalosporina
BR8900175A (pt) Processo para a preparacao de um produto de ciclopolidiorganossiloxano
PT93629A (pt) Processo para a preparacao de derivados de tieno-triazolo-diazepina
BR9001503A (pt) Processo para a preparacao de alquil-halogenossilanos

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19960902

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20020331